Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2007 1
2008 2
2009 1
2010 1
2011 2
2012 1
2013 4
2014 7
2015 8
2016 8
2017 8
2018 7
2019 7
2020 10
2021 6
2022 2
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

82 results

Results by year

Filters applied: . Clear all
Page 1
The novel norcantharidin derivative DCZ5417 suppresses multiple myeloma progression by targeting the TRIP13-MAPK-YWHAE signaling pathway.
Wang Y, Dong S, Hu K, Xu L, Feng Q, Li B, Wang G, Chen G, Zhang B, Jia X, Xu Z, Gao X, Zhang H, Xie Y, Lu M, Chang S, Song D, Wu X, Jia Q, Zhu H, Zhou J, Zhu W, Shi J. Wang Y, et al. Among authors: shi j. J Transl Med. 2023 Nov 27;21(1):858. doi: 10.1186/s12967-023-04739-7. J Transl Med. 2023. PMID: 38012658 Free PMC article.
Dihydrocelastrol induces antitumor activity and enhances the sensitivity of bortezomib in resistant multiple myeloma by inhibiting STAT3-dependent PSMB5 regulation.
Jin S, Li B, Zhang B, Gao X, Jia X, Xu L, Chang S, Hu K, Wang G, Xu Z, Zhang T, Song D, Yang G, Wu X, Zhu H, Huang C, Lu Y, Shi J, Zhu W, Chen G. Jin S, et al. Among authors: shi j. Acta Biochim Biophys Sin (Shanghai). 2023 Dec 25;55(12):1884-1891. doi: 10.3724/abbs.2023260. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 38009004 Free article.
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma.
Xu L, Wang Y, Wang G, Guo S, Yu D, Feng Q, Hu K, Chen G, Li B, Xu Z, Jia X, Lu Y, Zhang H, Gao X, Chang S, Wang H, Wu X, Song D, Yang G, Zhu H, Zhou J, Zhan F, Zhu W, Shi J. Xu L, et al. Among authors: shi j. Leukemia. 2023 Jul;37(7):1576-1579. doi: 10.1038/s41375-023-01925-w. Epub 2023 May 8. Leukemia. 2023. PMID: 37157015 No abstract available.
82 results